Topic Editors

Center for Craniofacial Molecular Biology, Norris Comprehensive Cancer Center, Department of Biochemistry and Molecular Medicine, University of Southern California, Los Angeles, CA, USA
Dr. Uttam K. Sinha
Tina and Rick Caruso Department of Otolaryngology Head and Neck Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA

Upper Aerodigestive Tract Cancer

Abstract submission deadline
closed (20 September 2023)
Manuscript submission deadline
20 December 2023
Viewed by
1824

Topic Information

Dear Colleagues,

Upper aerodigestive tract cancer (UATC) is aggressive malignancy derived from stratified epithelium of the upper aerodigestive tract, including oral cavity, larynx and oropharynx, and esophagus. Over one million new cases of UATC are diagnosed worldwide every year, with oral and esophageal cancers being the most common types. Human papillomavirus (HPV)-positive and -negative tumors are considered distinct diseases with distinguishing biological and clinical features. Effective targeted regimens are still unavailable for most UATC, which is highly aggressive. For example, 5-year survival rate of oral cancer patients is approximately 50%. Conventional cytotoxic chemotherapeutic options for oral cancer patients are limited and often ineffective. More importantly, the short-term effects (e.g., mucositis, odynophagia) and long-term toxicities (e.g., xerostomia, dysphagia, ototoxicity) from treatment substantially affect quality of life and rival the impact of the cancer itself. This Topic aims to highlight the latest advances in both basic and clinical studies on UATC, with the goal of promoting research of pathophysiology of UATC to advance the healthcare and life quality of its patients. Original research papers and review articles are welcomed.

Dr. De-Chen Lin
Dr. Uttam K. Sinha
Topic Editors

Keywords

  • head and neck cancer
  • esophageal cancer
  • human papillomavirus

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Cancers
cancers
5.2 7.4 2009 18.2 Days CHF 2900 Submit
Cells
cells
6.0 9.0 2012 18.8 Days CHF 2700 Submit
Current Oncology
curroncol
2.6 2.6 1994 18.4 Days CHF 2200 Submit
Journal of Clinical Medicine
jcm
3.9 5.4 2012 19.7 Days CHF 2600 Submit
Journal of Personalized Medicine
jpm
3.4 2.6 2011 20.2 Days CHF 2600 Submit

Preprints is a platform dedicated to making early versions of research outputs permanently available and citable. MDPI journals allow posting on preprint servers such as Preprints.org prior to publication. For more details about reprints, please visit https://www.preprints.org.

Published Papers (1 paper)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
Article
Role of Lower Esophageal Squamous Cell Carcinoma Margin Location on Abdominal Lymph Node Metastasis Risk
J. Clin. Med. 2023, 12(7), 2657; https://doi.org/10.3390/jcm12072657 - 03 Apr 2023
Viewed by 1081
Abstract
Background: Different sites of esophageal cancer are accompanied by different regional lymph node metastasis (LNM) risks. We aimed to investigate the impact of a lower tumor margin on abdominal LNM risk. Methods: We enrolled patients who underwent esophagectomy for esophageal squamous carcinoma (ESCC) [...] Read more.
Background: Different sites of esophageal cancer are accompanied by different regional lymph node metastasis (LNM) risks. We aimed to investigate the impact of a lower tumor margin on abdominal LNM risk. Methods: We enrolled patients who underwent esophagectomy for esophageal squamous carcinoma (ESCC) from 2014 to 2017 in West China Hospital. Overall survival (OS) analysis was performed. We measured the distance between the lower tumor margin and esophagogastric junction (LED) with upper gastrointestinal contrast-enhanced X-ray (UGCXR). Multivariate logistic regression analysis and propensity score matching (PSM) were performed to explore the relationship between LED and the risk of abdominal LNM. Abdominal LNM risk in ESCC was stratified based on the location of the lower tumor margin. A model predicting abdominal LNM risk was constructed and presented with a nomogram. Results: The included patients had an abdominal LNM rate of 48.29%. In multivariate logistic regression analysis, LED was identified as a risk factor for abdominal LNM. Subgroup analysis of middle ESCC showed that patients with an LED less than 10 cm had a significantly higher rate of abdominal LNM than those with an LED greater than 10 cm. The abdominal LNM rate in middle ESCC patients with an LED less than 10 cm was 32.2%, while it was 35.1% in lower ESCC patients whose lower tumor margin did not invade the esophagogastric junction (EGJ), which was comparable after PSM. Conclusions: LED could help surgeons evaluate the risk of abdominal LNM preoperatively and better guide dissection of abdominal lymph nodes according to risk level. Full article
(This article belongs to the Topic Upper Aerodigestive Tract Cancer)
Show Figures

Figure 1

Back to TopTop